“…), which shows that at least one monomer of SARS-CoV-2 spike RBD is in its “up” state [ [26] , [27] , [28] ]. Due to its pivotal role in the infection process, several studies targeted S with small molecules in an attempt to prevent the infection by blocking S-ACE2 binding [ 29 , 30 ].…”